Compare AstraZeneca plc (AZN) vs CSX Corporation (CSX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs CSX Corporation — how do they compare? AstraZeneca plc trades at $157.96 (market cap $248.14B), while CSX Corporation trades at $50.1 (market cap $92.55B). The key difference: AstraZeneca plc is far larger — about 2.7× CSX Corporation's market cap, and AstraZeneca plc pays the higher dividend (2.01%). Which is the better fit depends on your goals.
| AZN | CSX | |
|---|---|---|
Market Cap | $248.14B | $92.55B |
Sector | Health | Industrials |
52-Week High | $209.48 | $53.21 |
52-Week Low | $147.06 | $32.05 |
Enterprise Value | $275.41B | $110.52B |
Dividend Yield | 2.01% | 1.12% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About CSX Corporation
Operating in the Eastern United States, Class I railroad CSX generated revenue near $12.5 billion in 2021. On its more than 21,000 miles of track, CSX hauls shipments of coal (13% of consolidated revenue), chemicals (22%), intermodal containers (16%), automotive cargo (9%), and a diverse mix of other bulk and industrial merchandise.
Read more on CSX →
